susana mato

Univ P Vasco, Leioa, Euskadi, Spain 
"susana mato"
Mean distance: 18.32 (cluster 32)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bernal-Chico A, Manterola A, Cipriani R, et al. (2020) P2x7 receptors control demyelination and inflammation in the cuprizone model. Brain, Behavior, & Immunity - Health. 4: 100062
Huerga-Gómez A, Aguado T, Sánchez-de la Torre A, et al. (2020) Δ -Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo. Glia
Canedo-Antelo M, Serrano MP, Manterola A, et al. (2018) Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling Cascade. Frontiers in Molecular Neuroscience. 11: 333
Manterola A, Bernal-Chico A, Cipriani R, et al. (2018) Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis. Neuropharmacology
Mato S, Pilar-Cuéllar F, Valdizán EM, et al. (2018) Selective up-regulation of cannabinoid CB receptor coupling to Go-proteins in suicide victims with mood disorders. Biochemical Pharmacology
Manterola A, Bernal-Chico A, Cipriani R, et al. (2018) Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination. Biochemical Pharmacology
Gomis-González M, Matute C, Maldonado R, et al. (2016) Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model. Genes. 7
Borralleras C, Mato S, Amédée T, et al. (2016) Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome. Molecular Brain. 9: 76
Bernal-Chico A, Canedo M, Manterola A, et al. (2015) Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo. Glia. 63: 163-76
Busquets-Garcia A, Gomis-González M, Guegan T, et al. (2013) Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nature Medicine. 19: 603-7
See more...